Join Us Via Live Stream for the Following Sessions:
(5/16 9am EST.)
The MDGs, The Looming 2015 Deadline and The Pivotal Role of The Private Sector. The ambitious vision of the MDGs has guided much of the best and most innovative work of GBCHealth Member companies and the global organizations we work with. But the completion date of Dec 31, 2015 is fast approaching. GBCHealth's 2013 Conference will feature three major MDG blocks delving into child health (MDG 4), maternal health (MDG 5) and the three pandemics of HIV, malaria and tuberculosis (MDG 6). In partnership with the MDG Health Alliance, we will highlight new initiatives to accelerate progress through the explicit engagement of the private sector. MDG leaders-including UN Secretary General Ban Ki-moon and UN MDG Advocate Ray Chambers-will provide context and vision.
· Raymond G. Chambers, The U.N. Secretary-General's Special Envoy for Financing the Health Millennium Development Goals and for Malaria, United Nations
· Gary M. Cohen, Acting CEO, Executive Office, GBCHealth; Executive Vice President, BD (Becton, Dickinson & Company)
We know that access to contraception is a critical tool for women to determine their own and their families' future. We also know that it's fundamental to countries' ability to thrive economically, to be environmentally sustainable, and to achieve political stability. Decisions about where companies, governments and donors invest their development resources need to be based on impactful solutions, and mounting evidence points to family planning as one of the smartest choices we can make. In this session we will discuss new evidence on the return-on-investment of family planning, particularly when it comes to meeting the Millennium Development Goals; hear insights on how addressing the global unmet need for family planning can improve families' health, protect human rights, keep young women in school, and grow national economies; share recent progress made through new global calls to action such as FP2020; and highlight ways interested companies and other organizations can make a unique difference.
Kathy Calvin, President and CEO, United Nations Foundation
Babatunde Osotimehin, Executive Director, UNFPA
H.E. Dr. Christine Kaseba-Sata, First Lady of Zambia
(5/16, 3:30pm EST.)
Hear from Global Fund leadership, donors and private sector partners on why support for the Global Fund is more important now than ever, and how the private sector can play a leading role in ensuring success. As the Global Fund to Fight AIDS, TB and Malaria prepares to launch its Fourth Replenishment cycle, it is turning to donor governments and the private sector to increase their support. The upcoming replenishment will be critical to ensuring the Fund has sufficient resources to achieve its ambitious goals of saving 10 million lives and preventing 140-180 million new infections by 2016. By scaling up investments now, the Global Fund can help turn the tide against the diseases and save millions in investments down the road.
Laurie Garrett, Senior Fellow, Global Health, Council on Foreign Relations
Brian Brink, Chief Medical Officer, Anglo American plc
Mark Dybul, Executive Director, Global Fund to Fight AIDS, Tuberculosis and Malaria
Eric Goosby, U.S. Global AIDS Coordinator, Office of Global Health Diplomacy, U.S. Department of State
(5/17, 9am EST.)
Through a new, cutting-edge agreement with Pledge Guarantee for Health, leading public and private sector partners are joining together in an innovative financing partnership to increase the value delivered by donor aid. Join leaders from USAID, Swedish SIDA and private sector partners as they discuss how their new value-for-money partnership can help accelerate progress towards key global health goals: child health (MDG 4), maternal health (MDG 5) and HIV, malaria and tuberculosis (MDG 6).
Ray Chambers, The U.N. Secretary-General's Special Envoy for Financing the Health Millennium Development Goals and for Malaria, United Nations
Mikkel Vestergaard Frandsen, Chief Executive Officer, Vestergaard Frandsen
Anders Nordström, Ambassador for Global Health, Swedish Ministry for Foreign Affairs
Adam H. Schechter, Executive Vice President and President, Global Human Health, Merck